ArticleMediterranean journal of hematology and infectious diseases2019

Is it Safe and Cost Saving to Defer the CD4+ Cell Count Monitoring in Stable Patients on Art with More than 350 or 500 cells/μl?

Benedetto Maurizio Celesia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.